These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12536552)

  • 1. [Effects of angiotension II receptor antagonist on the level ET and NO in the patients with renal hypertension and protection of renal function].
    Zhou QL; Deng SL; Yang JH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):583-4. PubMed ID: 12536552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the relationship between plasma endothelin nitric oxide concentration and renal hypertension and renal function].
    Zhou Q; Sun M; Zhou H
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):381-3. PubMed ID: 12080656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The protection of renal function in the ACEI treatment of renal hypertension].
    Zhou QL; Yang JH; Chen LP
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):385-7. PubMed ID: 12206011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of angiotensin II receptor blockage on rats with experimental diabetes nephropathy in early stage].
    Yang L; Fan J; Mi X; Liu X; Xu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):317-9. PubMed ID: 12947726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions.
    Usta M; Dilek K; Yavuz M; Ersoy A; Güllülü M; Yurtkuran M
    Clin Nephrol; 2001 Mar; 55(3):260-2. PubMed ID: 11316250
    [No Abstract]   [Full Text] [Related]  

  • 7. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis.
    Dilek K; Usta M; Ersoy A; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
    Scand J Urol Nephrol; 2002; 36(6):443-6. PubMed ID: 12623509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat.
    Yamaguchi N; Jesmin S; Zaedi S; Shimojo N; Maeda S; Gando S; Koyama A; Miyauchi T
    Peptides; 2006 Sep; 27(9):2258-70. PubMed ID: 16725227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis.
    Yokohama S; Yoneda M; Haneda M; Okamoto S; Okada M; Aso K; Hasegawa T; Tokusashi Y; Miyokawa N; Nakamura K
    Hepatology; 2004 Nov; 40(5):1222-5. PubMed ID: 15382153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and nitric oxide in patients on chronic hemodialysis.
    Tomić M; Galesić K; Markota I
    Ren Fail; 2008; 30(9):836-42. PubMed ID: 18925520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of endothelin-1 and nitric oxide in the pathogenesis of hypertension in diabetic patients.
    Tomić M; Galesić K; Morović-Vergles J; Romić Z; Mikulić I
    Coll Antropol; 2008 Mar; 32(1):93-8. PubMed ID: 18496905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2006 Sep; 27(9):1213-21. PubMed ID: 16923343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension in chronic glomerulonephritis: detectability and treatment efficacy].
    Kutyrina IM; Martynov SA; Shvetsov MIu; Lifshits NL; Miroshnichenko NG; Golitsina EP; Varshavskiĭ VA
    Ter Arkh; 2004; 76(9):10-5. PubMed ID: 15532369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemaglobin levels and renal function in patients with and without hypertension].
    Hilden M; Hilden T
    Ugeskr Laeger; 1967 Sep; 129(38):1225-31. PubMed ID: 5597682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.